Christopher Mader

Christopher Mader is an accomplished professional in the biotechnology and life sciences sectors, currently serving as the Senior Director and Head of RWE Portfolio Strategy at Flatiron Health since November 2018. In this role, Mader leads the Portfolio Strategy group for the Real World Evidence Business Unit, focusing on developing long-term business strategies and innovative RWE solutions. Previously, Mader was a Senior Principal at Flatiron, overseeing business development for major biopharma partnerships, and held various roles in organizations such as Caris Life Sciences and the Broad Institute, where contributions included advancements in precision medicine and high-throughput screening technologies. Mader co-founded Dynamic Marching, a music education company, and has a strong academic background with a Ph.D. in Cell Biology from Yale University and a B.Sci. in Biological Sciences from the University of Notre Dame.